• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Koru Medical names former Fresenius Kabi VP as chief technology officer

April 19, 2022 By Sean Whooley

Koru Medical SystemsKoru Medical Systems (Nasdaq:KRMD) announced that it appointed medtech veteran Brian Case as its new chief technology officer (CTO).

With more than 20 years of experience in medtech R&D, Case joins after spending more than 16 years at Fresenius Kabi as VP of R&D. Before Fresenius Kabi, he served as an R&D program manager for advanced research at Cook Medical.

Case will lead product development and innovation at Chester, New York-based Koru as the company defines and executes a technology strategy to support its global drug delivery product portfolio, according to a news release.

Koru’s new CTO said in the release that the new role offers a high-potential opportunity to drive innovation and develop “best-in-class infusion solutions” to better serve the patient community.

“With his proven track record of value creation through R&D technology development, deployment of product development strategy, and merger and acquisition experience, we are confident Brian will be a catalyst to the Koru team,” Koru President and CEO Linda Tharby said in the release. “Brian is a great fit, with his value system, large and small company background, experiences and passion for the patient. He will be instrumental as we continue to define and execute Koru Medical’s product and technology strategy.

“His experience with global product and process development from the definition of customer needs to global market commercialization will pave the way for the company as we strengthen our technology roadmap to serve more patients, partners, and customers.”

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Personnel Tagged With: Koru Medical Systems, Personnel, Personnel Moves

IN CASE YOU MISSED IT

  • FDA lifts hold on Vertex’s insulin-producing cell therapy for diabetes
  • Retractable Technologies declares dividends
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • West Pharmaceutical Services debuts new needle syringe system
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS